Aloetherapeutics
1 known investors
Aloe Therapeutics develops AIM-001, a cell-based immunotherapy for solid tumors that is implanted locally during surgery to activate the immune system and enhance response to checkpoint immunotherapy. The therapy targets advanced cancer patients with limited treatment options.
BiotechMedical Devices